Literature DB >> 23070908

Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis.

Xiao-Juan Xu1, Li-Wei Zou, De-Bin Wang.   

Abstract

To perform a meta-analysis investigating the association of MTHFR C677T polymorphism and susceptibility of cervical cancer. All case-control studies published in English and Chinese with estimates of the relationship between MTHFR C677T polymorphism and risk of cervical cancer were analyzed using odds ratio (OR) with 95 % confidence interval (CI). A total of 10 studies (2,023 cases and 2,570 controls) were included in the meta-analysis. No significant association was observed between T allele and C allele (OR = 0.90; 95 %CI = 0.70-1.17; P = 0.43), and for genotype TT versus CC (OR = 1.09; 95 %CI = 0.74-1.61; P = 0.67), CT versus CC (OR = 0.95; 95 %CI = 0.75-1.20; P = 0.65), CT + TT versus CC (OR = 0.91; 95 %CI = 0.66-1.24; P = 0.55). The current meta-analysis results suggest that the MTHFR C677T polymorphism may not be associated with cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23070908     DOI: 10.1007/s11033-012-2056-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  29 in total

1.  Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers.

Authors:  Vidudala V T S Prasad; Harpreet Wilkhoo
Journal:  Onkologie       Date:  2011-08-22

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction?

Authors:  C M Ulrich; E Kampman; J Bigler; S M Schwartz; C Chen; R Bostick; L Fosdick; S A Beresford; Y Yasui; J D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-08       Impact factor: 4.254

4.  Common polymorphisms in methylenetetrahydrofolate reductase gene are associated with risks of cervical intraepithelial neoplasia and cervical cancer in women with low serum folate and vitamin B12.

Authors:  Seo-yun Tong; Mi Kyung Kim; Jae Kwan Lee; Jong Min Lee; Sang Woon Choi; Simonetta Friso; Eun-Seop Song; Kwang Beom Lee; Jung Pil Lee
Journal:  Cancer Causes Control       Date:  2010-11-05       Impact factor: 2.506

5.  Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population.

Authors:  Y Z Zheng; J Tong; X P Do; X Q Pu; B T Zhou
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

6.  Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease.

Authors:  Margreet Zoodsma; Ilja M Nolte; Martin Schipper; Elvira Oosterom; Gerrit van der Steege; Elisabeth G E de Vries; Gerard J te Meerman; Ate G J van der Zee
Journal:  Hum Genet       Date:  2005-01-06       Impact factor: 4.132

7.  Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer.

Authors:  Sokbom Kang; Jae Weon Kim; Gyeong Hoon Kang; Noh Hyun Park; Yong Sang Song; Soon Beom Kang; Hyo Pyo Lee
Journal:  Gynecol Oncol       Date:  2005-01       Impact factor: 5.482

8.  The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women.

Authors:  Jae Woong Sull; Sun Ha Jee; Sangwook Yi; Jong Eun Lee; Jong Sup Park; Sook Kim; Heechoul Ohrr
Journal:  Gynecol Oncol       Date:  2004-12       Impact factor: 5.482

9.  Analysis of 4 single-nucleotide polymorphisms in relation to cervical dysplasia and cancer development using a high-throughput ligation-detection reaction procedure.

Authors:  Helmut von Keyserling; Thomas Bergmann; Miriam Schuetz; Ursula Schiller; Jonas Stanke; Corinna Hoffmann; Achim Schneider; Hans Lehrach; Andreas Dahl; Andreas M Kaufmann
Journal:  Int J Gynecol Cancer       Date:  2011-12       Impact factor: 3.437

10.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

Authors:  P F Jacques; A G Bostom; R R Williams; R C Ellison; J H Eckfeldt; I H Rosenberg; J Selhub; R Rozen
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

View more
  4 in total

Review 1.  The association between cytotoxic T lymphocyte-associated antigen-4 and cervical cancer.

Authors:  Ping Liu; Li Xu; Yuan Sun; Zhiping Wang
Journal:  Tumour Biol       Date:  2013-12-10

2.  Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women.

Authors:  Nayara Nascimento Toledo Silva; Adriano de Paula Sabino; Alexandre Tafuri; Angélica Alves Lima
Journal:  BMC Med Genet       Date:  2019-06-06       Impact factor: 2.103

3.  Effects of methylenetetrahydrofolate reductase single-nucleotide polymorphisms on breast, cervical, ovarian, and endometrial cancer susceptibilities.

Authors:  Zheng Wang; Kai Li; Ling Ouyang; Hidasa Iko; Ahmad Javid Safi; Shan Gao
Journal:  Chronic Dis Transl Med       Date:  2021-08-12

4.  Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer.

Authors:  Anca Botezatu; Demetra Socolov; Iulia V Iancu; Irina Huica; Adriana Plesa; Carmen Ungureanu; Gabriela Anton
Journal:  J Cell Mol Med       Date:  2013-02-28       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.